Table 3:
Co-occurrence of observable findings and complications of PPV cesioflammea, cesiomarmorata or cesioflammea-cesiomarmorata overlap subtypes.
| Facial Vascular Involvement | |||
|---|---|---|---|
| Present | Absent | p-value |
|
| Seizures | 22/72 (31%) | 2/32 (6%) | 0.0066* |
| Developmental Delay | 8/54 (15%) | 2/24 (8%) | 0.43 |
| Glaucoma | 29/80 (36%) | 2/22 (9%) | 0.23 |
| Melanoma | 9/72 (13%) | 5/22 (23%) | 0.40 |
| Ocular Melanosis | |||
| Present | Absent | ||
| Ocular melanoma | 14/69 (20%) | NR | NA |
| Limb Asymmetry/Hypertrophy | |||
| Present | Absent | ||
| Venous malformations | 10/12 (83%) | 1/3 (33%) | 0.08 |
NR: Not reported;
*
Significant, by Z-test. References for this table are provided in supplementary table 3.